Status:
COMPLETED
Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD
Lead Sponsor:
Cox Health Systems
Conditions:
Attention Deficit Hyperactivity Disorder
INSOMNIA
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Methylphenidate may improve sleep in children with ADHD. By leaving Daytrana (methylphenidate) patch for a longer time then 9 hours, many children report short sleep latencies and better quality of sl...
Detailed Description
Once the optimal dose of Daytrana that controlled the ADHD symptoms is established. The patch will be removed 1, 2, and 3 hours before bed time in a random fashion, at weekly intervals, and parents wi...
Eligibility Criteria
Inclusion
- ADHD without significant comorbidity
Exclusion
- Cardiac disorder
- Hypertension
- Thyroid disease
- Glaucoma
- History of sudden death, motor tics and/or Tourette's syndrome
- Hypersensitivity to methylphenidate
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00989950
Start Date
December 1 2009
End Date
February 1 2011
Last Update
July 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Neurology of the Ozarks
Springfield, Missouri, United States, 65807